Competition from Him & Hers Health seems to be weighing on Novo Nordisk's stock. A half-hearted rating from Morgan Stanley yesterday isn't cheering investors up very much at all. Yet a new study ...
Novo Nordisk said on Wednesday it would begin selling its weight-loss drug Wegovy at a discounted price of $499 per month to patients paying cash, as it grapples with shifts to the competitive ...
This collaboration unites Novo Nordisk’s deep therapeutic knowledge ... selectivity and drug-like properties. Founded through MIT and based in Cambridge, Massachusetts, Gensaic's award-winning ...
Novo Nordisk (NVO) is not concerned by the ongoing US trade war and the 25% tariff set to go into effect for pharmaceutical companies next week. CEO Lars Jørgensen told reporters Thursday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results